Cargando…
Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation
Background: Calcium phosphate-based compounds are used to treat dental hypersensitivity (DH). Their long-term clinical behaviour needs further research. This study compared the 24-week effectiveness of Teethmate Desensitizer (TD), a pure tetracalcium phosphate (TTCP) and dicalcium phosphate dihydrat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955887/ https://www.ncbi.nlm.nih.gov/pubmed/31818019 http://dx.doi.org/10.3390/nano9121748 |
_version_ | 1783487032458215424 |
---|---|
author | Usai, Paolo Campanella, Vincenzo Sotgiu, Giovanni Spano, Giovanni Pinna, Roberto Eramo, Stefano Saderi, Laura Garcia-Godoy, Franklin Derchi, Giacomo Mastandrea, Giorgio Milia, Egle |
author_facet | Usai, Paolo Campanella, Vincenzo Sotgiu, Giovanni Spano, Giovanni Pinna, Roberto Eramo, Stefano Saderi, Laura Garcia-Godoy, Franklin Derchi, Giacomo Mastandrea, Giorgio Milia, Egle |
author_sort | Usai, Paolo |
collection | PubMed |
description | Background: Calcium phosphate-based compounds are used to treat dental hypersensitivity (DH). Their long-term clinical behaviour needs further research. This study compared the 24-week effectiveness of Teethmate Desensitizer (TD), a pure tetracalcium phosphate (TTCP) and dicalcium phosphate dihydrate (DCPD) powder/water, to that of Dentin Desensitizer (DD), and Bite & White ExSense (BWE), both of calcium phosphate crystallites. Methods: A total of 105 subjects were selected. A random table was utilised to form three groups of 35 subjects. DH was evaluated using the evaporative sensitivity, tactile sensitivity tests, and the visual analogue scale (VAS) of pain. Response was recorded before the application of the materials (Pre-1), immediately after (Post-0), at 1 week (Post-1), 4 weeks (Post-2), 12 weeks (Post-3) and 24 weeks (Post-4). The non-parametric distribution was assessed with the Shapiro–Wilk statistical test. Intra-group differences for the six time points were evaluated with the Friedman statistical test and the Kruskal–Wallis test. Results: All the materials decreased DH after 24 weeks in comparison to Pre-1. However, the TTCP/DCPD cement showed the greatest statistical efficiency. Conclusions: The significant decrease of VAS scores produced by TD in the long term suggest the material as the most reliable in the clinical relief of DH. |
format | Online Article Text |
id | pubmed-6955887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69558872020-01-23 Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation Usai, Paolo Campanella, Vincenzo Sotgiu, Giovanni Spano, Giovanni Pinna, Roberto Eramo, Stefano Saderi, Laura Garcia-Godoy, Franklin Derchi, Giacomo Mastandrea, Giorgio Milia, Egle Nanomaterials (Basel) Article Background: Calcium phosphate-based compounds are used to treat dental hypersensitivity (DH). Their long-term clinical behaviour needs further research. This study compared the 24-week effectiveness of Teethmate Desensitizer (TD), a pure tetracalcium phosphate (TTCP) and dicalcium phosphate dihydrate (DCPD) powder/water, to that of Dentin Desensitizer (DD), and Bite & White ExSense (BWE), both of calcium phosphate crystallites. Methods: A total of 105 subjects were selected. A random table was utilised to form three groups of 35 subjects. DH was evaluated using the evaporative sensitivity, tactile sensitivity tests, and the visual analogue scale (VAS) of pain. Response was recorded before the application of the materials (Pre-1), immediately after (Post-0), at 1 week (Post-1), 4 weeks (Post-2), 12 weeks (Post-3) and 24 weeks (Post-4). The non-parametric distribution was assessed with the Shapiro–Wilk statistical test. Intra-group differences for the six time points were evaluated with the Friedman statistical test and the Kruskal–Wallis test. Results: All the materials decreased DH after 24 weeks in comparison to Pre-1. However, the TTCP/DCPD cement showed the greatest statistical efficiency. Conclusions: The significant decrease of VAS scores produced by TD in the long term suggest the material as the most reliable in the clinical relief of DH. MDPI 2019-12-09 /pmc/articles/PMC6955887/ /pubmed/31818019 http://dx.doi.org/10.3390/nano9121748 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Usai, Paolo Campanella, Vincenzo Sotgiu, Giovanni Spano, Giovanni Pinna, Roberto Eramo, Stefano Saderi, Laura Garcia-Godoy, Franklin Derchi, Giacomo Mastandrea, Giorgio Milia, Egle Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation |
title | Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation |
title_full | Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation |
title_fullStr | Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation |
title_full_unstemmed | Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation |
title_short | Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation |
title_sort | effectiveness of calcium phosphate desensitising agents in dental hypersensitivity over 24 weeks of clinical evaluation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955887/ https://www.ncbi.nlm.nih.gov/pubmed/31818019 http://dx.doi.org/10.3390/nano9121748 |
work_keys_str_mv | AT usaipaolo effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT campanellavincenzo effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT sotgiugiovanni effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT spanogiovanni effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT pinnaroberto effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT eramostefano effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT saderilaura effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT garciagodoyfranklin effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT derchigiacomo effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT mastandreagiorgio effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation AT miliaegle effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation |